Pliant Therapeutics Inc Forecast, price target & analysts
Pliant Therapeutics Inc Target price 2024 - Analyst rating & recommendation
Pliant Therapeutics Inc Classifications & Recommendation:
Pliant Therapeutics Inc Target price
| Target price | $41.82 |
| Course | $10.86 |
| Price potential |
285.07%
register free of charge
|
| Number of estimates | 11 |
|
11 Analysts have issued a price target Pliant Therapeutics Inc 2025 .
The average Pliant Therapeutics Inc target price is $41.82.
This is
285.07%
register free of charge
$48.00
341.99%
register free of charge
$32.00
194.66%
register free of charge
|
|
| A rating was issued by 13 analysts: 13 Analysts recommend Pliant Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst estimates: Analysts believe that the Pliant Therapeutics Inc share has an average upside potential 2025 of
285.07%
register free of charge
|
Sales and margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Turnover Million $ | 1.58 | 1.83 |
| 83.69% | 15.54% | |
| EBITDA margin | -11,537.97% | -12,420.42% |
| 805.14% | 7.65% | |
| Net margin | -10,498.73% | -11,502.77% |
| 473.66% | 9.56% |
11 Analysts have issued a sales forecast Pliant Therapeutics Inc 2024 . The average Pliant Therapeutics Inc sales estimate is
This results in the following potential growth figures:
2 Analysts have issued an Pliant Therapeutics Inc EBITDA forecast 2024. The average Pliant Therapeutics Inc EBITDA estimate is
This results in the following potential growth figures and future EBITDA margins:
4 Pliant Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Pliant Therapeutics Inc net profit estimate is
This results in the following potential growth figures and future net margins:
Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Earnings per share $ | -2.75 | -3.48 |
| 6.46% | 26.55% | |
| P/E ratio | negative | |
| EV/Sales | 124.58 |
4 Analysts have issued a Pliant Therapeutics Inc forecast for earnings per share. The average Pliant Therapeutics Inc <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Based on analysts' sales estimates for 2024, the Pliant Therapeutics Inc share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
This results in the following potential growth figures and future valuations:
Pliant Therapeutics Inc...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
